TOP

Research Article

Split Viewer

Mol. Cells 2010; 30(6): 551-556

Published online November 23, 2010

https://doi.org/10.1007/s10059-010-0152-6

© The Korean Society for Molecular and Cellular Biology

Solution Structures and Molecular Interactions of Selective Melanocortin Receptor Antagonists

Chul-Jin Lee, Ji-Hye Yun, Sung-Kil Lim1, and Weontae Lee*

Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Korea, 1Department of Internal Medicine, College of Medicine, Yonsei University, Seoul 120-749, Korea

Correspondence to : *Correspondence: wlee@spin.yonsei.ac.kr

Received: July 19, 2010; Revised: September 11, 2010; Accepted: September 13, 2010

Abstract

The solution structures and inter-molecular interaction of the cyclic melanocortin antagonists SHU9119, JKC363, HS014, and HS024 with receptor molecules have been determined by NMR spectroscopy and molecular modeling. While SHU9119 is known as a nonselective antagonist, JKC363, HS014, and HS024 are selective for the melanocortin subtype-4 receptor (MC4R) involved in modulation of food intake. Data from NMR and molecular dynamics suggest that the conformation of the Trp9 sidechain in the three MC4R-selective antagonists is quite different from that of SHU9119. This result strongly supports the concept that the spatial orientation of the hydrophobic aromatic residue is more important for determining selectivity than the presence of a basic,“arginine-like” moiety responsible for biological activity. We propose that the conformation of hydrophobic residues of MCR antagonists is critical for receptor-specific selectivity.

Keywords antagonist, homology modeling, melanocortin, melanocortin receptor, nuclear magnetic resonance

Article

Research Article

Mol. Cells 2010; 30(6): 551-556

Published online December 31, 2010 https://doi.org/10.1007/s10059-010-0152-6

Copyright © The Korean Society for Molecular and Cellular Biology.

Solution Structures and Molecular Interactions of Selective Melanocortin Receptor Antagonists

Chul-Jin Lee, Ji-Hye Yun, Sung-Kil Lim1, and Weontae Lee*

Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Korea, 1Department of Internal Medicine, College of Medicine, Yonsei University, Seoul 120-749, Korea

Correspondence to:*Correspondence: wlee@spin.yonsei.ac.kr

Received: July 19, 2010; Revised: September 11, 2010; Accepted: September 13, 2010

Abstract

The solution structures and inter-molecular interaction of the cyclic melanocortin antagonists SHU9119, JKC363, HS014, and HS024 with receptor molecules have been determined by NMR spectroscopy and molecular modeling. While SHU9119 is known as a nonselective antagonist, JKC363, HS014, and HS024 are selective for the melanocortin subtype-4 receptor (MC4R) involved in modulation of food intake. Data from NMR and molecular dynamics suggest that the conformation of the Trp9 sidechain in the three MC4R-selective antagonists is quite different from that of SHU9119. This result strongly supports the concept that the spatial orientation of the hydrophobic aromatic residue is more important for determining selectivity than the presence of a basic,“arginine-like” moiety responsible for biological activity. We propose that the conformation of hydrophobic residues of MCR antagonists is critical for receptor-specific selectivity.

Keywords: antagonist, homology modeling, melanocortin, melanocortin receptor, nuclear magnetic resonance

Mol. Cells
Sep 30, 2023 Vol.46 No.9, pp. 527~572
COVER PICTURE
Chronic obstructive pulmonary disease (COPD) is marked by airspace enlargement (emphysema) and small airway fibrosis, leading to airflow obstruction and eventual respiratory failure. Shown is a microphotograph of hematoxylin and eosin (H&E)-stained histological sections of the enlarged alveoli as an indicator of emphysema. Piao et al. (pp. 558-572) demonstrate that recombinant human hyaluronan and proteoglycan link protein 1 (rhHAPLN1) significantly reduces the extended airspaces of the emphysematous alveoli by increasing the levels of TGF-β receptor I and SIRT1/6, as a previously unrecognized mechanism in human alveolar epithelial cells, and consequently mitigates COPD.

Share this article on

  • line

Related articles in Mol. Cells

Molecules and Cells

eISSN 0219-1032
qr-code Download